Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 5/20 | 0.48 |
| ▸ | MAOB | P27338 | 4/20 | 0.37 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6935844 | 0.98 | HSD11B1 (0.47) | HSD11B1MAOBMAOAKMT2AMEN1 | |
| SCHEMBL6933800 | 0.83 | HSD11B1 (0.48) | HSD11B1MAOBMAOAKMT2AMEN1 | |
| SCHEMBL6933292 | 0.83 | HSD11B1 (0.64) | HSD11B1MAOBMAOAKMT2AMEN1 | |
| SCHEMBL6934361 | 0.83 | HSD11B1 (0.51) | HSD11B1MAOBMAOAIDO1 | |
| Hydrochloric Acid SCHEMBL6934108 | 0.82 | HSD11B1 (0.62) | HSD11B1MAOBMAOAKMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL6931734 | 0.82 | HSD11B1 (0.47) | HSD11B1MAOBMAOAKMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL6930671 | 0.81 | HSD11B1 (0.50) | HSD11B1MAOBMAOAIDO1 | |
| Hydrochloric Acid SCHEMBL6934739 | 0.81 | HSD11B1 (0.45) | HSD11B1MAOBKMT2A | |
| Hydrochloric Acid SCHEMBL6935834 | 0.80 | HTR2C (0.40) | HSD11B1KMT2AMEN1RAB9ASLC6A2 | |
| SCHEMBL6933296 | 0.74 | SIGMAR1 (0.37) | HSD11B1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1051392-B1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RES LTD (GB) | 2003-12-17 | — | — | EP | claimed |
| US-6262106-B1 | Adamantanecarboximidamide derivatives and their use as NMDA antagonists | VERNALIS RESEARCH LIMITED (GB) | 2001-07-17 | — | — | US | claimed |
| EP-1051392-A1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RESEARCH LIMITED (GB) | 2000-11-15 | — | — | EP | claimed |
| WO-1999038841-A1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RESEARCH LIMITED (GB) | 1999-08-05 | — | — | WO | claimed |
| EP-1051392-B1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RES LTD (GB) | 2003-12-17 | — | — | EP | disclosed |
| US-6262106-B1 | Adamantanecarboximidamide derivatives and their use as NMDA antagonists | VERNALIS RESEARCH LIMITED (GB) | 2001-07-17 | — | — | US | disclosed |
| EP-1051392-A1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RESEARCH LIMITED (GB) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999038841-A1 | ADAMANTANECARBOXIMIDAMIDE DERIVATIVES AND THEIR USE AS NMDA ANTAGONISTS | VERNALIS RESEARCH LIMITED (GB) | 1999-08-05 | — | — | WO | disclosed |